Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Cells|February 4, 2021
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast CancerNavid Sobhani, Anne Fassl, Giuseppina Mondani, et al.Genes|April 26, 2025
Current Trends in Liquid Biopsy Tracking Resistance in Molecular Breast Cancer-Targeted TherapiesRichard Tancredi, Navid Sobhani, Martina Catalano, et al.DNA and Cell Biology|December 28, 2023
Regulation of Cellular-Signaling Pathways by Mammalian Proteins Containing Bacterial EPIYA or EPIYA-Like Motifs Predicted to be PhosphorylatedMohammad Rasouli, Fatemeh Safari, Navid Sobhani, et al.World Journal of Clinical Oncology|January 10, 2019
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancerNavid Sobhani, Daniele Generali, Fabrizio Zanconati, et al.Cancers|October 27, 2022
The Role of Genomics and Proteomics in Lung Cancer Early Detection and TreatmentMohammad Hadi Abbasian, Ali M Ardekani, Navid Sobhani, et al.Cancers|September 14, 2024
Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert OpinionNavid Sobhani, Alberto D'Angelo, Matteo Pittacolo, et al.Journal of Experimental & Clinical Cancer Research : CR|March 19, 2026
The double-edged sword role of tumor-associated macrophages: preventing or causing resistance to immunotherapyRaheleh Roudi, Behnaz Beikzadeh, Babak Beikzadeh, et al.Investigational New Drugs|August 8, 2018
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancerNavid Sobhani, Daniele Generali, Alberto D'Angelo, et al.Expert Review of Clinical Pharmacology|May 13, 2020
Cabozantinib as a second-line treatment option in hepatocellular carcinomaAlberto D'Angelo, Navid Sobhani, Stefan Bagby, et al.Iscience|October 30, 2024
Erratum: Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2Praveen Neeli, Dafei Chai, Xu Wang, et al.Pageof 6